• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HILL-ROM BATESVILLE PROGRESSA FRAME; BED, AC-POWERED ADJUSTABLE HOSPITAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HILL-ROM BATESVILLE PROGRESSA FRAME; BED, AC-POWERED ADJUSTABLE HOSPITAL Back to Search Results
Model Number P7500A001677
Device Problems Use of Device Problem (1670); Insufficient Information (3190)
Patient Problem Pressure Sores (2326)
Event Date 12/30/2021
Event Type  malfunction  
Event Description
The customer initially reported experiencing grade 3/grade 4 pressure injuries among 13 patients with the use of the hillrom progressa bed.Follow up with the customer found that 7 patients were reported to have developed pressure injuries with use of the progressa bed.Each reported injury will be evaluated separately (patient 1-7).This evaluation is for patient 1, a (b)(6) year old male with a history of cardiac surgery and alveolar hemorrhage.It is noted this patient was admitted to the icu for 32 days and developed a stage 2 sacral and abdominal pressure injury.Medical intervention for the patient's pressure injuries included mepentol oli, purilon, mepilex and varihesive.This report was filed in our complaint handling system as complaint #(b)(4).
 
Manufacturer Narrative
The progressa bed is intended to be used to treat or prevent pulmonary or other complications associated with immobility, pressure ulcers, or for any other use where medical benefits may be derived from either continuous lateral rotation therapy or percussion/vibration therapy.The instructions for use (ifu) states the therapy surface is not a substitute for good nursing practice.The development of pressure injuries is multifactorial and cannot only be attributed to the performance of the surface or the progressa bed.Pressure injuries can develop within 2-6 hours when capillaries supplying the skin and subcutaneous tissues are compressed, causing an obstruction in blood flow, which ultimately leads to tissue necrosis.Position changes are key to pressure injury prevention and treatment.These changes need to be frequent, repositioning needs to avoid stress on the skin, and body positions need to minimize the risk of pressure on vulnerable areas.Prevention of pressure injuries involves a multidisciplinary approach including rapid identification of at-risk individuals such as those with diabetes, incontinence, impaired mobility, peripheral vascular disease, etc.And exercising a vigilant prevention protocol consisting of skincare, nutritional assessment reducing mechanical load, and utilizing support surfaces.A stage 2 pressure injury is characterized by partial-thickness skin loss no deeper than the dermis and can include intact or ruptured blisters.Stage 2 pressure injuries can heal very rapidly therefore treatment is focused on nutrition to support wound healing and keeping the area protected/covered and clean.A stage 2 pressure injury is considered to be a moderate injury and does not meet the definition of a serious injury or a serious deterioration in health.However, the functionality of this device could not be determined at the time of this evaluation as the investigation is ongoing.If this device were determined to have malfunctioned serious injury could occur.Therefore hillrom is cautiously reporting this event due to the potential for serious injury.No further information is available on the device at this time.The device is going to be inspected onsite by a hrc technician.Hillrom will submit a final report with investigation conclusion on this incident.
 
Manufacturer Narrative
The progressa bed is intended to be used to treat or prevent pulmonary or other complications associated with immobility, pressure ulcers, or for any other use where medical benefits may be derived from either continuous lateral rotation therapy or percussion/vibration therapy.The instructions for use (ifu) states the therapy surface is not a substitute for good nursing practice.The development of pressure injuries is multifactorial and cannot only be attributed to the performance of the surface or the progressa bed.Pressure injuries can develop within 2-6 hours when capillaries supplying the skin and subcutaneous tissues are compressed, causing an obstruction in blood flow, which ultimately leads to tissue necrosis.Position changes are key to pressure injury prevention and treatment.These changes need to be frequent, repositioning needs to avoid stress on the skin, and body positions need to minimize the risk of pressure on vulnerable areas.Prevention of pressure injuries involves a multidisciplinary approach including rapid identification of at-risk individuals such as those with diabetes, incontinence, impaired mobility, peripheral vascular disease, etc., and exercising a vigilant prevention protocol consisting of skincare, nutritional assessment reducing mechanical load, and utilizing support surfaces.The bed and surface has been thoroughly inspected by the hrc technician and it was confirmed that the bed is functioning correctly and in accordance with the technical manual.All values are within the ranges of the technical documentation.The pressures measured were in compliance with the expectations.No malfunction, the bed was performing within specifications.A stage 2 pressure injury is characterized by partial-thickness skin loss no deeper than the dermis and can include intact or ruptured blisters.Stage 2 pressure injuries can heal very rapidly therefore treatment is focused on nutrition to support wound healing and keeping the area protected/covered and clean.A stage 2 pressure injury is considered to be a moderate injury and does not meet the definition of a serious injury or a serious deterioration in health.A stage 2 pressure injury is considered to be a moderate injury and does not meet the definition of a serious injury or a serious deterioration in health.There was no malfunction of the device, no serious injury or serious deterioration in the state of health associated with this event.Therefore hillrom does not consider this event reportable.
 
Event Description
The customer initially reported experiencing grade 3/grade 4 pressure injuries among 13 patients with the use of the hillrom progressa bed.Follow up with the customer found that 7 patients were reported to have developed pressure injuries with use of the progressa bed.Each reported injury will be evaluated separately (patient 1-7).This evaluation is for patient 1, a 59-year old male with a history of cardiac surgery and alveolar hemorrhage.It is noted this patient was admitted to the icu for 32 days and developed a stage 2 sacral and abdominal pressure injury.Medical intervention for the patient's pressure injuries included mepentol oli, purilon, mepilex and varihesive.This report was filed in our complaint handling system as complaint #(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGRESSA FRAME
Type of Device
BED, AC-POWERED ADJUSTABLE HOSPITAL
Manufacturer (Section D)
HILL-ROM BATESVILLE
1069 state route 46 east
batesville IN 47006
Manufacturer Contact
sarah oreilly
1069 state route 46 east
batesville, IN 47006
8129310130
MDR Report Key13368894
MDR Text Key286647942
Report Number1824206-2022-00037
Device Sequence Number1
Product Code FNL
UDI-Device Identifier00887761000100
UDI-Public010088776100010011211030
Combination Product (y/n)N
Reporter Country CodeSP
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberP7500A001677
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/30/2021
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Age59 YR
Patient SexMale
-
-